| Serial Number | 98593158 |
| Word Mark | PA INSIGHTS |
| Filing Date | Monday, June 10, 2024 |
| Status | 748 - STATEMENT OF USE - TO EXAMINER |
| Status Date | Tuesday, April 14, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 3, 2025 |
| Goods and Services | Software as a service (SAAS) services featuring software for reviewing pharmacy accreditation and re-accreditation; Software as a service (SAAS) services featuring software for monitoring compliance with pharmacy regulations, requirements, and audits; Software as a service (SAAS) services featuring software for prior authorization initiation, processing, support and analysis; Software as a service (SAAS) services featuring software for prior authorization analysis, namely approval rating, response time, difficulty estimation, workflow predictions, appeal likelihood, appeal outcome estimation, and denial predictions and rationale; Software as a service (SAAS) services featuring software for providing information and actionable intelligence for prior authorizations and providing guidance as to complexity, difficulty in completing, and likelihood for denial during the prior authorization process; Software as a service (SAAS) services featuring software for facilitating the onboarding of patients to new medications, providing ongoing patient education and facilitation of patient compliance to therapy; Software as a service (SAAS) services featuring software using artificial intelligence for prior authorization analysis, namely approval rating, response time, difficulty estimation, workflow predictions, appeal likelihood, appeal outcome estimation, and denial predictions and rationale |
| Goods and Services | Business management consulting, strategic planning and business advisory services provided to medical and pharmaceutical industries; Business management of logistics for others; Business management of reimbursement programs for others; Business services provided to a network of health care providers, namely, the negotiation and execution of contracts with health care payors; Consulting services in the field of patient relationship management for healthcare providers; Cost management for the health care benefit plans of others; Cost price analysis; Logistics management in the field of healthcare; Negotiation of business contracts for others; New product commercialization services; Pharmaceutical cost management services and drug utilization review services; Business assistance, advisory and consulting services in the field of product distribution, production, operations, logistics, and supply chains; Business assistance, advisory and consulting services in the field of medical product approval; Professional credentialing verification services in the field of healthcare, namely, verifying the skills and knowledge of licensed professionals on behalf of others; Providing business intelligence services in the fields of medical devices, pharmaceuticals and the life sciences; Providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval |
| NOT AVAILABLE | PA |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 10, 2024 |
| Primary Code | 035 |
| First Use Anywhere Date | Friday, June 7, 2024 |
| First Use In Commerce Date | Friday, June 7, 2024 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 10, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | Friday, June 7, 2024 |
| First Use In Commerce Date | Friday, June 7, 2024 |
| Party Name | D2 Pharma Consulting LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Chesterfield, MO 63017 US |
| Party Name | D2 Pharma Consulting LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Chesterfield, MO 63017 US |
| Event Date | Event Description |
| Monday, June 10, 2024 | NEW APPLICATION ENTERED |
| Saturday, December 14, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, December 17, 2024 | ASSIGNED TO EXAMINER |
| Wednesday, January 8, 2025 | NON-FINAL ACTION WRITTEN |
| Wednesday, January 8, 2025 | NON-FINAL ACTION E-MAILED |
| Wednesday, January 8, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, April 7, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, April 7, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, April 7, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, May 1, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, May 28, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, June 3, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, June 3, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 30, 2025 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Friday, November 7, 2025 | TEAS STATEMENT OF USE RECEIVED |
| Friday, November 7, 2025 | USE AMENDMENT FILED |
| Tuesday, April 14, 2026 | STATEMENT OF USE PROCESSING COMPLETE |